Press Release LEO Pharma Presents Phase 3 Results of Delgocitinib Cream for Adults with Moderate to Severe Chronic Hand Eczema (CHE) at EADV 2023 13 October 2023
Press Release LEO Pharma Presents New Long-Term Data on Use of Adtralza® (tralokinumab) to Treat Moderate-to-Severe Atopic Dermatitis (AD) 13 October 2023
Press Release Almirall’s Lebrikizumab Improves Signs and Symptoms of Moderate-to-Severe Atopic Dermatitis (AD) in Patients Inadequately Controlled With or Ineligible for Cyclosporine1 13 October 2023
Press Release AM Best Europe Insurance Market Briefing to Examine State of Industry Amid Escalating Challenges; Beazley CEO to Deliver Keynote 13 October 2023
Press Release Meiji Seika Pharma Presents Positive Findings from Phase II Study of ME3183, Novel Highly-Potent Selective PDE4 Inhibitor, in Patients With Plaque Psoriasis at EADV Congress 2023 13 October 2023
Press Release Alpaca and Japan’s SBI Holdings Announce Partnership and USD15 Million Strategic Investment to Accelerate Alpaca’s Asian Business 13 October 2023
Press Release tZERO ATS to Provide Combined Primary and Secondary Offerings as tZERO Securities 13 October 2023
Press Release Unveiling Chaos LakeDB: The First Lake Database for Live Search+SQL+GenAI Analytics 13 October 2023
